文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

舌下微循环评估脓毒性休克复苏疗效:一项队列研究

Assessment of Sublingual Microcirculation to Evaluate the Efficacy of Resuscitation Therapy in Septic Shock Patients: A Cohort Study.
PubMed 文献 · Shock · 2025-09-25
一句话结论脓毒性休克患者复苏后6小时舌下微循环PPV>68.6%与更好的组织氧合、器官功能及28天预后相关,作者提出其可能作为未来早期目标导向治疗的目标。

该队列研究纳入72例脓毒性休克患者(排除心功能受损包括脓毒症诱导的心肌病),在复苏前和复苏后6小时测量舌下微循环参数,并收集大循环参数、血气分析及器官预后指标。结果显示复苏后舌下微循环变量与传统循环变量无显著相关性;PPV 6h对28天预后预测效能最高,优于传统变量中最佳的PcvO2 6h。以组织氧合(Lac 24h)、器官功能障碍进展(△APACHE II 3d和△SOFA 3d)及长期结局(不良预后和28天死亡率)锚定,确定PPV 6h最佳阈值为68.6%;达到该阈值的患者微循环改善、器官功能障碍减轻、长期结局更好。作者认为舌下微循环可作为反映复苏治疗效果的辅助工具,并提出PPV 6h>68.6%可能作为未来研究的早期目标导向治疗目标。

要点

  • 复苏后6小时舌下微循环PPV对28天预后预测效能最高,优于传统变量中最佳的PcvO2 6h。
  • 以Lac 24h、△APACHE II 3d、△SOFA 3d及长期结局锚定,PPV 6h最佳阈值为68.6%。
  • 达到PPV 6h>68.6%的患者乳酸水平更低且清除更快、APACHE II和SOFA评分更低、需持续肾脏替代治疗更少。
  • 达到PPV 6h>68.6%的患者长期结局更好:血管活性药物使用更少、28天死亡率更低。
  • 复苏后舌下微循环变量与传统循环变量无显著相关性。

适用人群与场景

  • 脓毒性休克患者,最终分析72例,排除心功能受损包括脓毒症诱导的心肌病患者。

诊断标准与关键阈值

  • PPV 6h最佳阈值为68.6%,锚定于组织氧合(Lac 24h)、器官功能障碍进展(△APACHE II 3d和△SOFA 3d)及长期结局(不良预后和28天死亡率)。

研究设计与关键结果

  • 研究类型为队列研究,样本量72例脓毒性休克患者,排除心功能受损包括脓毒症诱导的心肌病。
  • 在复苏前和复苏后6小时测量舌下微循环参数,并收集大循环参数、血气分析变量及器官预后指标。
  • 复苏后舌下微循环变量与传统循环变量无显著相关性。
  • PPV 6h对28天预后预测效能最高,优于传统变量中最佳的PcvO2 6h。
  • 达到PPV 6h>68.6%的患者乳酸水平更低且清除更快、APACHE II和SOFA评分更低、需持续肾脏替代治疗更少。
  • 达到PPV 6h>68.6%的患者血管活性药物使用更少、28天死亡率更低。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为舌下微循环可作为反映复苏治疗效果的辅助工具,并提出PPV 6h>68.6%可能作为未来研究的早期目标导向治疗目标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Determining the endpoint of resuscitation in septic shock is essential to enhance effectiveness, prevent over-resuscitation, and improve outcomes. We designed this study to investigate whether sublingual microcirculation monitoring can serve as an effective marker for assessing the efficacy of resuscitation therapy in septic shock.

METHODS: A total of 72 septic shock patients were included in our final analysis, excluding those with heart function impairments, including sepsis-induced cardiomyopathy. Sublingual microcirculation parameters were measured at two time points: before resuscitation and 6 hours postresuscitation. Additionally, the values of macrocirculatory parameters, blood gas analysis variables, and organ prognosis indicators were collected at multiple time points before and after resuscitation. Spearman correlation analysis was performed to assess the correlations among these variables. Furthermore, the receiver operating characteristic curve analysis method was employed to evaluate the predictive performance of sublingual microcirculation parameters and other relevant factors for patient prognosis. Finally, we determined the optimal threshold of proportion of perfused vessel (PPV) 6h by anchoring it to three key aspects: tissue oxygenation (Lac 24h ), organ dysfunction progression (△APACHE II 3d and △SOFA 3d ), and long-term outcomes (adverse prognosis and 28-day mortality).

RESULTS: Sublingual microcirculation variables postresuscitation showed no significant correlation with conventional circulation variables. PPV 6h had the highest predictive efficacy for 28-day prognosis, better than PcvO2 6h , the best predictor among conventional variables. The optimal PPV 6h threshold (68.6%) was determined using three key criteria mentioned above. Patients meeting this threshold after resuscitation showed improved microcirculation (lower lactate levels and faster clearance), reduced organ dysfunction (lower APACHE II and SOFA scores, less need for continuous renal replacement therapy), and better long-term outcomes (fewer vasoactive drugs, 28-day lower mortality).

CONCLUSIONS: Our study highlights the potential utility of sublingual microcirculation as an adjunctive tool for reflecting the effectiveness of resuscitation therapy and proposes that the PPV 6h >68.6% may serve as a target for early goal-directed therapy in future studies.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhang X, Zhang H, Jin R, et al. Assessment of Sublingual Microcirculation to Evaluate the Efficacy of Resuscitation Therapy in Septic Shock Patients: A Cohort Study. Shock. 2025. PMID: 41031817. doi:10.1097/SHK.0000000000002708

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。